Phase I reactions transform compounds through oxidation, reduction or hydrolysis
CJC-1295 progressed through Phase 1/2 clinical trials under ConjuChem in the mid-2000s with documented prolonged GH and IGF-1 stimulation (PMID 16352683, PMID 16822960)
The most common side effects of taking CARNIGLO TABLET are vomiting, nausea, stomach pain, diarrhea, headache, an abnormal taste, or body odour (a fishy smell)
Tirzepatide affects blood sugar, thyroid function, pancreatic activity, and cardiovascular parameters
Injectable Formulations: The subcutaneous injection formulations (Ozempic and Wegovy) contain semaglutide dissolved in a buffer solution with additional excipients as specified in their FDA-approved labeling